Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	611M 1.86B 534M 493M 454M 857M 58.88B 876M 5.89B 2.32B 28.84B 2.3B 2.25B 99.27B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	611M 1.86B 534M 493M 454M 857M 58.88B 876M 5.89B 2.32B 28.84B 2.3B 2.25B 99.27B	EV / Sales 2026 *	8.97x	EV / Sales 2027 *	7.19x
Free-Float	90.48%	Yield 2026 *	-	Yield 2027 *	-

07-16	Sound Minds Behavioral announced that it expects to receive $0.5 million in funding from BrainsWay Ltd.	CI
07-16	BrainsWay Announces Strategic Investment in Sound Minds Behavioral	MT
06-29	Brainsway Ltd. Presents Positive Data From Largest Real-World Study Of Deep TMS In Patients With Comorbid PTSD And Major Depressive Disorder	CI
06-09	BrainsWay Presents First SWIFT Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting	CI
05-18	Hopemark Health, Ltd announced that it expects to receive funding from BrainsWay Ltd.	CI
05-18	Brainsway announces minority-stake investment in Hopemark Health	RE
05-18	BrainsWay Takes Minority Stake in Hopemark Health	MT
05-13	BrainsWay Ltd., Q1 2026 Earnings Call, May 13, 2026
05-13	BrainsWay Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	Brainsway Ltd. Reiterates Earnings Guidance for the Year 2026	CI
03-26	Brainsway Provides $6 Million Milestone-Based Convertible Loan to Neurolief	MT
03-19	Brainsway Pays $1 Million Milestone Payment to Axis Management	MT
03-18	Axis Management Company, Inc. announced that it has received $3.3 million in funding from BrainsWay Ltd.	CI

11-13	BrainsWay Ltd. Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder in Adolescents Aged 15 to 21	CI
25-05-14	Oppenheimer Adjusts Brainsway Price Target to $15 From $13, Maintains Outperform Rating	MT
24-05-09	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
24-05-09	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT
23-11-16	Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating	MT

07-16	BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral	AQ
06-29	BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder	AQ
06-22	BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives	AQ
06-09	BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting	AQ
05-18	BrainsWay Announces Minority-Stake Investment in Hopemark Health	AQ

Manager	Title	Age	Since
Hadar Levy CEO	Chief Executive Officer	54	2023-02-12
Yiftach Roth CTO	Chief Tech/Sci/R&D Officer	56	2006-04-30
Ido Marom DFI	Director of Finance/CFO	50	2023-05-22

BrainsWay Ltd. Stock TEL AVIV STOCK EXCHANGE

Stocks

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Valuation: BrainsWay Ltd.

Latest news : BrainsWay Ltd.

Last Transcript: BrainsWay Ltd.

Analysts' recommendations: BrainsWay Ltd.

Press Releases: BrainsWay Ltd.

Quotes and Performance

Managers and Directors: BrainsWay Ltd.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Director	Title	Age	Since
David Zacut CHM	Chairman	74	2002-12-31
Avner Hagai BRD	Director/Board Member	70	2006-10-31
Abraham Zangen BRD	Director/Board Member	56	2019-06-16

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRAINSWAY LTD.	+10.37%	+15.65%	-	-	596M
THERMO FISHER SCIENTIFIC, INC.	-1.97%	+1.03%	+25.30%	+1.37%	202B
DANAHER CORPORATION	-0.58%	+2.40%	+4.64%	-14.27%	145B
INTUITIVE SURGICAL, INC.	-14.15%	-15.08%	-33.08%	-2.38%	142B
BOSTON SCIENTIFIC CORPORATION	-1.32%	-1.65%	-57.93%	-16.31%	66.32B
EDWARDS LIFESCIENCES CORPORATION	-2.40%	-7.03%	+12.54%	-7.47%	50.58B
SIEMENS HEALTHINEERS AG	-0.11%	+1.53%	-24.62%	-31.81%	44.81B
AGILENT TECHNOLOGIES, INC.	-3.41%	-2.11%	+12.98%	+11.17%	38.44B
WATERS CORPORATION	-2.44%	-1.98%	+24.27%	+36.75%	37.13B
GE HEALTHCARE TECHNOLOGIES INC.	-4.00%	-2.52%	-17.27%	-22.32%	29.89B
Average	-0.52%	-2.30%	-5.91%	-5.03%	84.07B
Weighted average by Cap.	-1.30%	-2.16%	-3.12%	-5.14%

	2026 *	2027 *
Net sales	68.15M 207M 59.56M 54.96M 50.66M 95.48M 6.56B 97.6M 657M 258M 3.21B 256M 250M 11.06B	84.98M 258M 74.27M 68.53M 63.17M 119M 8.18B 122M 819M 322M 4.01B 319M 312M 13.8B
Net income	13.23M 40.21M 11.56M 10.67M 9.84M 18.54M 1.27B 18.95M 128M 50.16M 624M 49.69M 48.6M 2.15B	22.2M 67.47M 19.4M 17.91M 16.5M 31.11M 2.14B 31.8M 214M 84.18M 1.05B 83.39M 81.56M 3.61B
Net Debt	-	-